BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Akcea Therapeutics

Akcea Therapeutics logo

Founded
2014
Clinical Trials
13
Publications
27

Technologies

Antisense Oligonucleotides

Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc., is a development and commercialization company focused on transforming serious cardiometabolic lipid disorders. Akcea&s;s portfolio spans multiple targets and disease states, including both rare and more common lipid disorders, using advanced RNA-targeted antisense therapeutics.

Become a Member to view additional information about this company

Posts Mentioning This Company